Repurposing anti-retroviral medications for brain tumor treatment: The RETREAT trial

FHS
June 21, 2024
4:35 pm

Drugs developed to combat HIV and AIDS are being trialed for the first time in patients with multiple brain tumors.

Medicare wants to send $9 billion to 340B hospitals — coupled with cuts

WASHINGTON — Medicare is planning to send $9 billion in lump-sum payments to more than 1,600 hospitals that participate in a drug discount program after

July 7, 2023

IMS-001 by Imstem Biotechnology for Secondary Progressive Multiple Sclerosis (SPMS): Likelihood of Approval

Share this article GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug

February 8, 2024

What it Will Take To Trust Healthcare AI Models? – Digital Health

Dr. Stephen L. Ondra, Chief Medical Adviser at MITRE Dr. Brian Anderson, Chief Digital Health Physician at MITRE As ChatGPT and similar Large Language Model

November 10, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.